A. Akhmanova and M. Steinmetz, Microtubule +TIPs at a glance, Journal of Cell Science, vol.123, issue.20, pp.3415-3419, 2010.
DOI : 10.1242/jcs.062414

E. Morrison, Action and interactions at microtubule ends, Cellular and Molecular Life Sciences, vol.64, issue.3, pp.307-317, 2007.
DOI : 10.1007/s00018-007-6360-3

L. Su and Y. Qi, Characterization of Human MAPRE Genes and Their Proteins, Genomics, vol.71, issue.2, pp.142-149, 2001.
DOI : 10.1006/geno.2000.6428

A. Panopoulos, M. Howell, R. Fotedar, and R. Margolis, Glioblastoma motility occurs in the absence of actin polymer, Molecular Biology of the Cell, vol.22, issue.13, pp.2212-2220, 2011.
DOI : 10.1091/mbc.E10-10-0849

A. Pagano, S. Honore, R. Mohan, R. Berges, A. Akhmanova et al., Epothilone B inhibits migration of glioblastoma cells by inducing microtubule catastrophes and affecting EB1 accumulation at microtubule plus ends, Biochemical Pharmacology, vol.84, issue.4, pp.432-443, 2012.
DOI : 10.1016/j.bcp.2012.05.010

A. Rovini, G. Gauthier, R. Berges, A. Kruczynski, D. Braguer et al., Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status, PLoS ONE, vol.71, issue.6, p.65694, 2013.
DOI : 10.1371/journal.pone.0065694.s003

URL : https://hal.archives-ouvertes.fr/hal-01406320

R. Mohan, E. Katrukha, H. Doodhi, I. Smal, E. Meijering et al., End-binding proteins sensitize microtubules to the action of microtubule-targeting agents, Proceedings of the National Academy of Sciences, vol.110, issue.22, pp.8900-8905, 2013.
DOI : 10.1073/pnas.1300395110

X. Dong, F. Liu, L. Sun, M. Liu, D. Li et al., Oncogenic function of microtubule end-binding protein 1 in breast cancer, The Journal of Pathology, vol.368, pp.361-369, 2010.
DOI : 10.1002/path.2662

Y. Wang, X. Zhou, H. Zhu, S. Liu, C. Zhou et al., Overexpression of EB1 in human esophageal squamous cell carcinoma (ESCC) may promote cellular growth by activating ??-catenin/TCF pathway, Oncogene, vol.11, issue.44, pp.6637-6645, 2005.
DOI : 10.1002/ijc.20642

R. Nishigaki, M. Osaki, M. Hiratsuka, T. Toda, K. Murakami et al., Proteomic identification of differentially-expressed genes in human gastric carcinomas, PROTEOMICS, vol.89, issue.12, pp.3205-3213, 2005.
DOI : 10.1002/pmic.200401307

Y. Sugihara, H. Taniguchi, R. Kushima, H. Tsuda, D. Kubota et al., Proteomic-based identification of the APC-binding protein EB1 as a candidate of novel tissue biomarker and therapeutic target for colorectal cancer, Journal of Proteomics, vol.75, issue.17, pp.5342-5355, 2012.
DOI : 10.1016/j.jprot.2012.06.013

K. Fujii, T. Kondo, H. Yokoo, T. Yamada, K. Iwatsuki et al., Proteomic study of human hepatocellular carcinoma using two-dimensional difference gel electrophoresis with saturation cysteine dye, PROTEOMICS, vol.140, issue.5, pp.1411-1422, 2012.
DOI : 10.1002/pmic.200401004

T. Orimo, H. Ojima, N. Hiraoka, S. Saito, T. Kosuge et al., Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma, Hepatology, vol.141, issue.6, pp.1851-1863, 2008.
DOI : 10.1002/hep.22552

R. Stupp, W. Mason, M. Van-den-bent, M. Weller, B. Fisher et al., Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005.
DOI : 10.1056/NEJMoa043330

M. Van-den-bent, A. Brandes, M. Taphoorn, J. Kros, M. Kouwenhoven et al., Adjuvant Procarbazine, Lomustine, and Vincristine Chemotherapy in Newly Diagnosed Anaplastic Oligodendroglioma: Long-Term Follow-Up of EORTC Brain Tumor Group Study 26951, Journal of Clinical Oncology, vol.31, issue.3, pp.344-350, 2013.
DOI : 10.1200/JCO.2012.43.2229

A. Tchoghandjian, N. Baeza, C. Colin, M. Cayre, P. Metellus et al., A2B5 Cells from Human Glioblastoma have Cancer Stem Cell Properties, Brain Pathology, vol.4, issue.1, pp.211-221, 2010.
DOI : 10.1111/j.1750-3639.2009.00269.x

URL : https://hal.archives-ouvertes.fr/hal-00507521

A. Tchoghandjian, N. Baeza-kallee, C. Beclin, P. Metellus, C. Colin et al., Cortical and Subventricular Zone Glioblastoma-Derived Stem-Like Cells Display Different Molecular Profiles and Differential In Vitro and In Vivo Properties, Annals of Surgical Oncology, vol.70, issue.5, pp.608-619, 2012.
DOI : 10.1245/s10434-011-2093-5

URL : https://hal.archives-ouvertes.fr/hal-00839131

C. Hartmann, J. Meyer, J. Balss, D. Capper, W. Mueller et al., Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas, Acta Neuropathologica, vol.324, issue.2, pp.469-74, 2009.
DOI : 10.1007/s00401-009-0561-9

D. Capper, S. Weissert, J. Balss, A. Habel, J. Meyer et al., Characterization of R132H Mutation-specific IDH1 Antibody Binding in Brain Tumors, Brain Pathology, vol.324, issue.1, pp.245-54, 2010.
DOI : 10.1111/j.1750-3639.2009.00352.x

D. Parsons, S. Jones, X. Zhang, J. Lin, R. Leary et al., An Integrated Genomic Analysis of Human Glioblastoma Multiforme, Science, vol.321, issue.5897, pp.1807-1819, 2008.
DOI : 10.1126/science.1164382

T. Gorlia, M. Van-den-bent, M. Hegi, R. Mirimanoff, M. Weller et al., Nomograms for predicting survival of patients with newly diagnosed glioblastoma: prognostic factor analysis of EORTC and NCIC trial 26981-22981/CE.3, The Lancet Oncology, vol.9, issue.1, pp.26981-2298129, 2008.
DOI : 10.1016/S1470-2045(07)70384-4

A. Rivera, C. Pelloski, M. Gilbert, H. Colman, D. L. Cruz et al., MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastoma, Neuro-Oncology, vol.12, issue.2, pp.116-137, 2010.
DOI : 10.1093/neuonc/nop020

Y. Wen, C. Eng, J. Schmoranzer, N. Cabrera-poch, E. Morris et al., EB1 and APC bind to mDia to stabilize microtubules downstream of Rho and promote cell migration, Nature Cell Biology, vol.114, issue.9, pp.820-830, 2004.
DOI : 10.1016/S1046-2023(02)00023-3

K. Zaoui, K. Benseddik, P. Daou, D. Salaun, and A. Badache, ErbB2 receptor controls microtubule capture by recruiting ACF7 to the plasma membrane of migrating cells, Proceedings of the National Academy of Sciences, vol.107, issue.43, pp.18517-18522, 2010.
DOI : 10.1073/pnas.1000975107

K. Zaoui, S. Honore, D. Isnardon, D. Braguer, and A. Badache, Memo???RhoA???mDia1 signaling controls microtubules, the actin network, and adhesion site formation in migrating cells, The Journal of Cell Biology, vol.183, issue.3, pp.401-408, 2008.
DOI : 10.1371/journal.pbio.0050317

M. Liu, S. Yang, Y. Wang, H. Zhu, S. Yan et al., EB1 acts as an oncogene via activating beta-catenin/TCF pathway to promote cellular growth and inhibit apoptosis

W. Zeng, K. Navaratne, R. Prayson, and R. Weil, Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme, Journal of Clinical Pathology, vol.60, issue.2, pp.218-221, 2007.
DOI : 10.1136/jcp.2006.036806

C. Katsetos, E. Dráberová, B. Smejkalová, G. Reddy, L. Bertrand et al., Class III ??-Tubulin and ??-Tubulin are Co-expressed and Form Complexes in Human Glioblastoma Cells, Neurochemical Research, vol.64, issue.8, pp.1387-98, 2007.
DOI : 10.1007/s11064-007-9321-1

E. Dráberová, S. Vinopal, G. Morfini, P. Liu, V. Sládková et al., Microtubule-Severing ATPase Spastin in Glioblastoma: Increased Expression in Human Glioblastoma Cell Lines and Inverse Roles in Cell Motility and Proliferation, Journal of Neuropathology & Experimental Neurology, vol.70, issue.9, pp.811-837, 2011.
DOI : 10.1097/NEN.0b013e31822c256d

A. Bouissou, C. Vérollet, H. De-forges, L. Haren, Y. Bellaïche et al., ??-Tubulin Ring Complexes and EB1 play antagonistic roles in microtubule dynamics and spindle positioning, The EMBO Journal, vol.16, issue.2, pp.114-142, 2014.
DOI : 10.1002/embj.201385967

S. Maurer, N. Cade, G. Bohner, N. Gustafsson, E. Boutant et al., EB1 Accelerates Two Conformational Transitions Important for Microtubule Maturation and Dynamics, Current Biology, vol.24, issue.4, pp.372-84, 2014.
DOI : 10.1016/j.cub.2013.12.042

URL : https://hal.archives-ouvertes.fr/hal-00965697

A. Rovini, G. Gauthier, R. Bergès, A. Kruczynski, D. Braguer et al., Anti-Migratory Effect of Vinflunine in Endothelial and Glioblastoma Cells Is Associated with Changes in EB1 C-Terminal Detyrosinated/Tyrosinated Status, PLoS ONE, vol.71, issue.6, p.8, 2013.
DOI : 10.1371/journal.pone.0065694.s003

URL : https://hal.archives-ouvertes.fr/hal-01406320

L. Grand, M. Rovini, A. Bourgarel-rey, V. Honore, S. Bastonero et al., ROS-mediated EB1 phosphorylation through Akt/GSK3?? pathway: implication in cancer cell response to microtubule-targeting agents, Oncotarget, vol.5, issue.10, pp.3408-3431, 2014.
DOI : 10.18632/oncotarget.1982

URL : https://hal.archives-ouvertes.fr/hal-01310723

L. Sun, J. Gao, X. Dong, M. Liu, D. Li et al., EB1 promotes Aurora-B kinase activity through blocking its inactivation by protein phosphatase 2A, Proceedings of the National Academy of Sciences, vol.105, issue.20, pp.7153-7161, 2008.
DOI : 10.1073/pnas.0710018105

A. Mialhe, L. Lafanechere, I. Treilleux, N. Peloux, C. Dumontet et al., Tubulin detyrosination is a frequent occurrence in breast cancers of poor prognosis, Cancer Res, vol.61, pp.5024-5027, 2001.

P. Bieling, S. Kandels-lewis, I. Telley, J. Van-dijk, C. Janke et al., CLIP-170 tracks growing microtubule ends by dynamically recognizing composite EB1/tubulin-binding sites, The Journal of Cell Biology, vol.183, issue.7, pp.1223-1233, 2008.
DOI : 10.1038/nsmb1291

D. Calligaris, C. Manatschal, M. Marcellin, C. Villard, B. Monsarrat et al., Tyrosine-dependent capture of CAP-Gly domain???containing proteins in complex mixture by EB1 C-terminal peptidic probes, Journal of Proteomics, vol.75, issue.12, pp.3605-3616, 2012.
DOI : 10.1016/j.jprot.2012.04.006

L. Peris, M. Thery, J. Faure, Y. Saoudi, L. Lafanechere et al., Tubulin tyrosination is a major factor affecting the recruitment of CAP-Gly proteins at microtubule plus ends, The Journal of Cell Biology, vol.88, issue.6, pp.839-849, 2006.
DOI : 10.1016/S0092-8674(00)80676-5

URL : https://hal.archives-ouvertes.fr/inserm-00380096

C. Colin, B. Voutsinos-porche, I. Nanni, F. Fina, P. Metellus et al., High expression of cathepsin B and plasminogen activator inhibitor type-1 are strong predictors of survival in glioblastomas, Acta Neuropathologica, vol.132, issue.6, pp.745-754, 2009.
DOI : 10.1007/s00401-009-0592-2

F. Ducray, A. De-reynies, O. Chinot, A. Idbaih, D. Figarella-branger et al., An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-line chemotherapy in glioblastoma patients, Molecular Cancer, vol.9, issue.1, p.234, 2010.
DOI : 10.1186/1476-4598-9-234

URL : https://hal.archives-ouvertes.fr/inserm-00668209

D. Macdonald, T. Cascino, S. Schold, J. Cairncross, and J. , Response criteria for phase II studies of supratentorial malignant glioma., Journal of Clinical Oncology, vol.8, issue.7, pp.1277-1280, 1990.
DOI : 10.1200/JCO.1990.8.7.1277

N. Baeza, M. Weller, Y. Yonekawa, P. Kleihues, and H. Ohgaki, PTEN methylation and expression in glioblastomas, Acta Neuropathologica, vol.106, issue.5, pp.479-485, 2003.
DOI : 10.1007/s00401-003-0748-4

R. Berges, J. Balzeau, A. Peterson, and J. Eyer, A Tubulin Binding Peptide Targets Glioma Cells Disrupting Their Microtubules, Blocking Migration, and Inducing Apoptosis, Molecular Therapy, vol.20, issue.7, pp.1367-1377, 2012.
DOI : 10.1038/mt.2012.45

V. Vichai and K. Kirtikara, Sulforhodamine B colorimetric assay for cytotoxicity screening, Nature Protocols, vol.129, issue.3, pp.1112-1116, 2006.
DOI : 10.1038/nprot.2006.179

F. Jiang, X. Zhang, S. Kalkanis, Z. Zhang, H. Yang et al., Combination Therapy with Antiangiogenic Treatment and Photodynamic Therapy for the Nude Mouse Bearing U87 Glioblastoma, Photochemistry and Photobiology, vol.25, issue.0
DOI : 10.1007/s00280-005-1017-0

A. Kruczynski, M. Poli, R. Dossi, E. Chazottes, G. Berrichon et al., Anti-angiogenic, vascular-disrupting and anti-metastatic activities of vinflunine, the latest vinca alkaloid in clinical development, European Journal of Cancer, vol.42, issue.16, pp.2821-2832, 2006.
DOI : 10.1016/j.ejca.2006.06.019

E. Redgate, M. Deutsch, and S. Boggs, Time of death of CNS tumor-bearing rats can be reliably predicted by body weight-loss patterns, Lab Anim Sci, vol.41, pp.269-273, 1991.

K. Applegate, S. Besson, A. Matov, M. Bagonis, K. Jaqaman et al., plusTipTracker: Quantitative image analysis software for the measurement of microtubule dynamics, Journal of Structural Biology, vol.176, issue.2, pp.168-84, 2011.
DOI : 10.1016/j.jsb.2011.07.009